Cargando…
Acute hypoglycemia and risk of cardiac arrhythmias in insulin-treated type 2 diabetes and controls
OBJECTIVE: Hypoglycemia is associated with an increased risk of cardiovascular disease including cardiac arrhythmias. We investigated the effect of hypoglycemia in the setting of acute glycemic fluctuations on cardiac rhythm and cardiac repolarization in insulin-treated patients with type 2 diabetes...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345897/ https://www.ncbi.nlm.nih.gov/pubmed/34085953 http://dx.doi.org/10.1530/EJE-21-0232 |
_version_ | 1783734738935087104 |
---|---|
author | Andersen, Andreas Bagger, Jonatan I Baldassarre, Maria P A Christensen, Mikkel B Abelin, Kirsten U Faber, Jens Pedersen-Bjergaard, Ulrik Holst, Jens J Lindhardt, Tommi B Gislason, Gunnar Knop, Filip K Vilsbøll, Tina |
author_facet | Andersen, Andreas Bagger, Jonatan I Baldassarre, Maria P A Christensen, Mikkel B Abelin, Kirsten U Faber, Jens Pedersen-Bjergaard, Ulrik Holst, Jens J Lindhardt, Tommi B Gislason, Gunnar Knop, Filip K Vilsbøll, Tina |
author_sort | Andersen, Andreas |
collection | PubMed |
description | OBJECTIVE: Hypoglycemia is associated with an increased risk of cardiovascular disease including cardiac arrhythmias. We investigated the effect of hypoglycemia in the setting of acute glycemic fluctuations on cardiac rhythm and cardiac repolarization in insulin-treated patients with type 2 diabetes compared with matched controls without diabetes. DESIGN: A non-randomized, mechanistic intervention study. METHODS: Insulin-treated patients with type 2 diabetes (n = 21, age (mean ± s.d.): 62.8 ± 6.5 years, BMI: 29.0 ± 4.2 kg/m(2), HbA1c: 6.8 ± 0.5% (51.0 ± 5.4 mmol/mol)) and matched controls (n = 21, age: 62.2 ± 8.3 years, BMI 29.2 ± 3.5 kg/m(2), HbA1c: 5.3 ± 0.3% (34.3 ± 3.3 mmol/mol)) underwent a sequential hyperglycemic and hypoglycemic clamp with three steady-states of plasma glucose: (i) fasting plasma glucose, (ii) hyperglycemia (fasting plasma glucose +10 mmol/L) and (iii) hyperinsulinemic hypoglycemia (plasma glucose < 3.0 mmol/L). Participants underwent continuous ECG monitoring and blood samples for counterregulatory hormones and plasma potassium were obtained. RESULTS: Both groups experienced progressively increasing heart rate corrected QT (Fridericia’s formula) interval prolongations during hypoglycemia ((∆mean (95% CI): 31 ms (16, 45) and 39 ms (24, 53) in the group of patients with type 2 diabetes and controls, respectively) with similar increases from baseline at the end of the hypoglycemic phase (P = 0.43). The incidence of ventricular premature beats increased significantly in both groups during hypoglycemia (P = 0.033 and P < 0.0001, respectively). One patient with type 2 diabetes developed atrial fibrillation during recovery from hypoglycemia. CONCLUSIONS: In insulin-treated patients with type 2 diabetes and controls without diabetes, hypoglycemia causes clinically significant and similar increases in cardiac repolarization that might increase vulnerability for serious cardiac arrhythmias and sudden cardiac death. |
format | Online Article Text |
id | pubmed-8345897 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Bioscientifica Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-83458972021-08-10 Acute hypoglycemia and risk of cardiac arrhythmias in insulin-treated type 2 diabetes and controls Andersen, Andreas Bagger, Jonatan I Baldassarre, Maria P A Christensen, Mikkel B Abelin, Kirsten U Faber, Jens Pedersen-Bjergaard, Ulrik Holst, Jens J Lindhardt, Tommi B Gislason, Gunnar Knop, Filip K Vilsbøll, Tina Eur J Endocrinol Clinical Study OBJECTIVE: Hypoglycemia is associated with an increased risk of cardiovascular disease including cardiac arrhythmias. We investigated the effect of hypoglycemia in the setting of acute glycemic fluctuations on cardiac rhythm and cardiac repolarization in insulin-treated patients with type 2 diabetes compared with matched controls without diabetes. DESIGN: A non-randomized, mechanistic intervention study. METHODS: Insulin-treated patients with type 2 diabetes (n = 21, age (mean ± s.d.): 62.8 ± 6.5 years, BMI: 29.0 ± 4.2 kg/m(2), HbA1c: 6.8 ± 0.5% (51.0 ± 5.4 mmol/mol)) and matched controls (n = 21, age: 62.2 ± 8.3 years, BMI 29.2 ± 3.5 kg/m(2), HbA1c: 5.3 ± 0.3% (34.3 ± 3.3 mmol/mol)) underwent a sequential hyperglycemic and hypoglycemic clamp with three steady-states of plasma glucose: (i) fasting plasma glucose, (ii) hyperglycemia (fasting plasma glucose +10 mmol/L) and (iii) hyperinsulinemic hypoglycemia (plasma glucose < 3.0 mmol/L). Participants underwent continuous ECG monitoring and blood samples for counterregulatory hormones and plasma potassium were obtained. RESULTS: Both groups experienced progressively increasing heart rate corrected QT (Fridericia’s formula) interval prolongations during hypoglycemia ((∆mean (95% CI): 31 ms (16, 45) and 39 ms (24, 53) in the group of patients with type 2 diabetes and controls, respectively) with similar increases from baseline at the end of the hypoglycemic phase (P = 0.43). The incidence of ventricular premature beats increased significantly in both groups during hypoglycemia (P = 0.033 and P < 0.0001, respectively). One patient with type 2 diabetes developed atrial fibrillation during recovery from hypoglycemia. CONCLUSIONS: In insulin-treated patients with type 2 diabetes and controls without diabetes, hypoglycemia causes clinically significant and similar increases in cardiac repolarization that might increase vulnerability for serious cardiac arrhythmias and sudden cardiac death. Bioscientifica Ltd 2021-06-03 /pmc/articles/PMC8345897/ /pubmed/34085953 http://dx.doi.org/10.1530/EJE-21-0232 Text en © The authors https://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Clinical Study Andersen, Andreas Bagger, Jonatan I Baldassarre, Maria P A Christensen, Mikkel B Abelin, Kirsten U Faber, Jens Pedersen-Bjergaard, Ulrik Holst, Jens J Lindhardt, Tommi B Gislason, Gunnar Knop, Filip K Vilsbøll, Tina Acute hypoglycemia and risk of cardiac arrhythmias in insulin-treated type 2 diabetes and controls |
title | Acute hypoglycemia and risk of cardiac arrhythmias in insulin-treated type 2 diabetes and controls |
title_full | Acute hypoglycemia and risk of cardiac arrhythmias in insulin-treated type 2 diabetes and controls |
title_fullStr | Acute hypoglycemia and risk of cardiac arrhythmias in insulin-treated type 2 diabetes and controls |
title_full_unstemmed | Acute hypoglycemia and risk of cardiac arrhythmias in insulin-treated type 2 diabetes and controls |
title_short | Acute hypoglycemia and risk of cardiac arrhythmias in insulin-treated type 2 diabetes and controls |
title_sort | acute hypoglycemia and risk of cardiac arrhythmias in insulin-treated type 2 diabetes and controls |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345897/ https://www.ncbi.nlm.nih.gov/pubmed/34085953 http://dx.doi.org/10.1530/EJE-21-0232 |
work_keys_str_mv | AT andersenandreas acutehypoglycemiaandriskofcardiacarrhythmiasininsulintreatedtype2diabetesandcontrols AT baggerjonatani acutehypoglycemiaandriskofcardiacarrhythmiasininsulintreatedtype2diabetesandcontrols AT baldassarremariapa acutehypoglycemiaandriskofcardiacarrhythmiasininsulintreatedtype2diabetesandcontrols AT christensenmikkelb acutehypoglycemiaandriskofcardiacarrhythmiasininsulintreatedtype2diabetesandcontrols AT abelinkirstenu acutehypoglycemiaandriskofcardiacarrhythmiasininsulintreatedtype2diabetesandcontrols AT faberjens acutehypoglycemiaandriskofcardiacarrhythmiasininsulintreatedtype2diabetesandcontrols AT pedersenbjergaardulrik acutehypoglycemiaandriskofcardiacarrhythmiasininsulintreatedtype2diabetesandcontrols AT holstjensj acutehypoglycemiaandriskofcardiacarrhythmiasininsulintreatedtype2diabetesandcontrols AT lindhardttommib acutehypoglycemiaandriskofcardiacarrhythmiasininsulintreatedtype2diabetesandcontrols AT gislasongunnar acutehypoglycemiaandriskofcardiacarrhythmiasininsulintreatedtype2diabetesandcontrols AT knopfilipk acutehypoglycemiaandriskofcardiacarrhythmiasininsulintreatedtype2diabetesandcontrols AT vilsbølltina acutehypoglycemiaandriskofcardiacarrhythmiasininsulintreatedtype2diabetesandcontrols |